PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Recruiting · NCT07142291 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 2 | 2026-07-23 | NCT07142291 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PhenoNet, Inc. | 1 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.